Us Bancorp \De\ Alector, Inc. Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Alector, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 13,654 shares of ALEC stock, worth $23,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,654

Previous 13,762 0.78%

Holding current value

$23,894

Previous $64,000 60.94%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$1.72 - $6.06 $185 - $654	-108 Reduced 0.78%	13,654 $25,000
Q3 2024 Oct 28, 2024	SELL	$4.34 - $6.58 $39,888 - $60,476	-9,191 Reduced 40.04%	13,762 $64,000
Q1 2024 May 07, 2024	BUY	$5.69 - $8.08 $95,222 - $135,218	16,735 Added 269.14%	22,953 $138,000
Q4 2023 Feb 09, 2024	BUY	$3.77 - $8.39 $15,950 - $35,498	4,231 Added 212.93%	6,218 $49,000
Q3 2023 Nov 03, 2023	SELL	$5.2 - $8.77 $187 - $315	-36 Reduced 1.78%	1,987 $12,000
Q2 2023 Aug 09, 2023	BUY	$5.86 - $7.93 $3,211 - $4,345	548 Added 37.15%	2,023 $12,000
Q4 2022 Feb 13, 2023	SELL	$6.88 - $9.55 $1,486 - $2,062	-216 Reduced 12.77%	1,475 $13,000
Q3 2022 Oct 27, 2022	BUY	$8.19 - $13.2 $1,220 - $1,966	149 Added 9.66%	1,691 $16,000
Q2 2022 Aug 01, 2022	BUY	$7.65 - $14.24 $2,455 - $4,571	321 Added 26.29%	1,542 $16,000
Q1 2022 May 11, 2022	BUY	$13.02 - $20.78 $2,643 - $4,218	203 Added 19.94%	1,221 $18,000
Q4 2021 Feb 11, 2022	SELL	$19.35 - $25.54 $14,860 - $19,614	-768 Reduced 43.0%	1,018 $21,000
Q3 2021 Nov 10, 2021	SELL	$21.65 - $39.49 $3,940 - $7,187	-182 Reduced 9.25%	1,786 $41,000
Q1 2021 Apr 28, 2021	BUY	$14.84 - $22.23 $11,872 - $17,784	800 Added 68.49%	1,968 $40,000
Q4 2020 Feb 04, 2021	SELL	$9.4 - $16.7 $5,940 - $10,554	-632 Reduced 35.11%	1,168 $18,000
Q3 2020 Nov 10, 2020	SELL	$10.54 - $24.96 $11,341 - $26,856	-1,076 Reduced 37.41%	1,800 $19,000
Q2 2020 Aug 07, 2020	BUY	$21.87 - $33.11 $1,662 - $2,516	76 Added 2.71%	2,876 $70,000
Q1 2020 May 13, 2020	BUY	$16.25 - $35.28 $37,375 - $81,144	2,300 Added 460.0%	2,800 $68,000
Q4 2019 Feb 04, 2020	BUY	$14.17 - $20.3 $3,542 - $5,075	250 Added 100.0%	500 $9,000
Q3 2019 Nov 08, 2019	BUY	$14.42 - $22.2 $3,605 - $5,550	250 New	250 $4,000

Others Institutions Holding ALEC

# of Institutions

164

Shares Held

57.5M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $144M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account